Ind Swift Ltd
NSE:INDSWFTLTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ind Swift Ltd
Cash Interest Paid
Ind Swift Ltd
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ind Swift Ltd
NSE:INDSWFTLTD
|
Cash Interest Paid
₹634.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
78%
|
CAGR 10-Years
7%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash Interest Paid
₹4.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash Interest Paid
₹389.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash Interest Paid
₹2.7B
|
CAGR 3-Years
90%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Cash Interest Paid
₹3.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash Interest Paid
₹2.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Ind Swift Ltd
Glance View
Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm operates in both domestic and export markets. The company is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The firm is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. The company operates through various divisions, such as Herba Plus Division, Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Herba Plus Division is engaged in the manufacturing of ayurvedic and pharmaceutical products, such as general category formulations, beta lactam, steroids and hormones, cephalosporins, oncological, soft gelatin capsules, and herbal and nutraceuticals. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte.
See Also
What is Ind Swift Ltd's Cash Interest Paid?
Cash Interest Paid
634.3m
INR
Based on the financial report for Mar 31, 2024, Ind Swift Ltd's Cash Interest Paid amounts to 634.3m INR.
What is Ind Swift Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
7%
Over the last year, the Cash Interest Paid growth was 0%. The average annual Cash Interest Paid growth rates for Ind Swift Ltd have been 6% over the past three years , 78% over the past five years , and 7% over the past ten years .
